Browsing Tag
baxdrostat
3 posts
New Baxdrostat Phase III data reveal significant ambulatory blood pressure reduction in resistant patients
Find out how AstraZeneca’s Baxdrostat achieved significant blood pressure reductions in resistant hypertension patients in Phase III trials.
AstraZeneca wraps up $1.8bn acquisition of CinCor Pharma
AstraZeneca has closed the previously announced $1.8 billion acquisition of US biopharmaceutical company CinCor Pharma. Under the terms…
AstraZeneca to acquire US biopharma company CinCor Pharma for $1.8bn
AstraZeneca has agreed to acquire CinCor Pharma for a transaction value of around $1.8 billion, which includes an…